Ethical considerations of e-cigarette use for tobacco harm reduction

Respiratory Research

Volumn 17, Issue 1, 2016, Pages

  Franck, Caroline ^a   Filion, Kristian B ^a,b   Kimmelman, Jonathan ^b   Grad, Roland ^b   Eisenberg, Mark J ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

E cigarettes; Ethics; Harm reduction

Indexed keywords

ADVERTISING; ELECTRONIC CIGARETTE; HARM REDUCTION; HEALTH HAZARD; HUMAN; MARKETING; MEDICAL ETHICS; PRODUCT SAFETY; PUBLIC HEALTH SERVICE; REVIEW; SMOKING; SMOKING CESSATION; SMOKING HABIT; COMMERCIAL PHENOMENA; DIRECT-TO-CONSUMER ADVERTIZING; ECONOMICS; ETHICS; LUNG DISEASE; PROCEDURES; PROTECTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKE; VAPING;

CIGARETTE SMOKING; COMMERCE; CONSUMER PRODUCT SAFETY; DIRECT-TO-CONSUMER ADVERTISING; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HARM REDUCTION; HUMANS; LUNG DISEASES; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKE; SMOKING CESSATION; VAPING;

EID: 84977485406     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-016-0370-3     Document Type: Review

References (68)

1. Franck C, Budlovsky T, Windle SB, Filion KB, Eisenberg MJ. Electronic cigarettes in North America. Circulation. 2014;129(19):1945-52. doi: 10.1161/circulationaha.113.006416.
2. Roberts MJ, Reich MR. Ethical analysis in public health. Lancet. 2002;359(9311):1055-9. doi: 10.1016/S0140-6736(02)08097-2.
3. US Department of Health and Human Services. The health consequences of smoking--50 years of progress. A report of the surgeon general. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
4. Rostron BL, Chang CM, Pechacek TF. Estimation of cigarette smoking-attributable morbidity in the United States. JAMA Intern Med. 2014. doi: 10.1001/jamainternmed.2014.5219.
5. Linn MW, Stein S. Reasons for smoking among extremely heavy smokers. Addict Behav. 1985;10(2):197-201. doi: 10.1016/0306-4603(85)90028-0.
6. Phillips CV. Debunking the claim that abstinence is usually healthier for smokers than switching to a low-risk alternative, and other observations about anti-tobacco-harm-reduction arguments. Harm Reduct J. 2009;6. doi: 10.1186/1477-7517-6-29.
7. Caponnetto P, Cibella F, Mancuso S, Campagna D, Arcidiacono G, Polosa R. Effect of a nicotine-free inhalator as part of a smoking-cessation programme. Eur Respir J. 2011;38(5):1005-11. doi: 10.1183/09031936.00109610.
8. Erickson CK. Addiction essentials: the Go-to guide for clinicians and patients (Go-to guides for mental health). W. W. Norton. 2011.
9. Steinberg MB, Zimmermann MH, Delnevo CD, Lewis MJ, Shukla P, Coups EJ, et al. E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices. J Gen Intern Med. 2014;29(11):1444-50. doi: 10.1007/s11606-014-2889-7.
10. Etter J-F. Electronic cigarettes: a survey of users. BMC Public Health. 2010;10(1):231.
11. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J et al. Electronic cigarettes for smoking cessation: A randomised controlled trial. The Lancet.382(9905):1629-37. doi:http://dx.doi.org/ 10.1016/S0140-6736(13)61842-5
12. Palmateer NE, Taylor A, Goldberg DJ, Munro A, Aitken C, Shepherd SJ, et al. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One. 2014;9(8):e104515. doi: 10.1371/journal.pone.0104515.
13. Farrell M, Gowing L, Marsden J, Ling W, Ali R. Effectiveness of drug dependence treatment in HIV prevention. Int J Drug Policy. 2005;16(1):67-75. doi: 10.1016/j.drugpo.2005.02.008.
14. Wodak A, Cooney A. Effectiveness of sterile needle and syringe programmes. Int J Drug Policy. 2005;16:S31-44. doi: 10.1016/j.drugpo.2005.02.004.
15. Maziak W. Harm reduction at the crossroads: the case of e-cigarettes. Am J Prev Med. 2014;47(4):505-7. doi: 10.1016/j.amepre.2014.06.022.
16. U.S. Food and Drug Administration. Nicotine Replacement Therapy Labels May Change. 2015. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm345087.htm. Accessed 20 March 2015.
17. Zhu SH, Melcer T, Sun JC, Rosbrook B, Pierce JP. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med. 2000;18(4):305-11. doi: 10.1016/s0749-3797(00)00124-0.
18. Marlatt GA, Larimer ME, Witkiewitz K. Harm Reduction, 2nd ed: Pragmatic Strategies for Managing High-Risk Behaviors. New York: Guilford Publications; 2011.
19. Fox BJ, Cohen JE. Tobacco harm reduction: a call to address the ethical dilemmas. Nicotine Tob Res. 2002;4 Suppl 2:S81-S7. doi: 10.1080/1462220021000032861.
20. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Pol. 2011;32(1):16-31. doi: 10.1057/jphp.2010.41.
21. Berridge V. Electronic cigarettes and history. Lancet. 2014;383(9936):2204-5.
22. Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control. 2003;12(4):349-59. doi: 10.1136/tc.12.4.349.
23. Kozlowski LT. Effect of smokeless tobacco product marketing and use on population harm from tobacco use - Policy perspective for tobacco-risk reduction. Am J Prev Med. 2007;33(6):S379-S86. doi: 10.1016/j.amepre.2007.09.015.
24. Hall W, Gartner C. Supping with the Devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products. Public Health. 2009;123(3):287-91. doi: 10.1016/j.puhe.2008.12.018.
25. McKee M, Capewell S. Evidence about electronic cigarettes: a foundation built on rock or sand? BMJ. 2015;351:h4863. doi: 10.1136/bmj.h4863.
26. Faden R, Shebaya S. Public Health Ethics. The Stanford Encyclopedia of Philosophy (Summer 2010 Edition), Edward N. Zalta (ed.). http://plato.stanford.edu/entries/publichealth-ethics/. Accessed 4 Dec 2014.
27. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013;15(1):158-66. doi: 10.1093/ntr/nts103.
28. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23(2):ii36-40. doi: 10.1136/tobaccocontrol-2013-051470.
29. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: A prospective 6-month pilot study. BMC Public Health. 2011;11. doi: 10.1186/1471-2458-11-786
30. Wieslander G, Norback D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med. 2001;58(10):649-55. doi: 10.1136/oem.58.10.649.
31. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014;129(19):1972-86. doi: 10.1161/circulationaha.114.007667.
32. Novotny TE, Carlin D. Ethical and legal aspects of global tobacco control. Tob Control. 2005;14(2):ii26-30. doi: 10.1136/tc.2004.008284.
33. Etter J-F, Bullen C. Electronic cigarette: Users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011;106(11):2017-28. doi: 10.1111/j.1360-0443.2011.03505.x.
34. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst. Rev. 2014 doi: 10.1002/14651858.CD010216.pub2
35. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PloS One. 2013.8(6). doi: 10.1371/journal.pone.0066317.
36. Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health. 2014;14:1159. doi: 10.1186/1471-2458-14-1159.
37. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. 2014;9(5):537-46. doi: 10.1007/s11739-013-0977-z.
38. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013;10(2):446-61. doi: 10.3390/ijerph10020446.
39. Hatsukami DK, Kotlyar M, Allen S, Jensen J, Li S, Le C, et al. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest. 2005;128(4):2528-37. doi: 10.1378/chest.128.4.2528.
40. Hatsukami DK, Le CT, Zhang Y, Joseph AM, Mooney ME, Carmella SG, et al. Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidem Biomar. 2006;15(12):2355-8. doi: 10.1158/1055-9965.epi-06-0240.
41. Benowitz NL, Jacob P, Kozlowski LT, Yu L. Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med. 1986;315(21):1310-3. doi: 10.1056/nejm198611203152102.
42. Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA. 2005;294(12):1505-10. doi: 10.1001/jama.294.12.1505.
43. Carpenter MJ, Hughes JR, Keely JP. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res. 2003;5(2):155-62. doi: 10.1080/1462220031000073685.
44. Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res. 2006;8(6):739-49. doi: 10.1080/14622200600789726.
45. King BA, Patel R, Nguyen K, Dube SR. Trends in awareness and use of electronic cigarettes among U.S. adults, 2010-2013. Nicotine Tob Res. 2014. doi: 10.1093/ntr/ntu191
46. Kandel ER, Kandel DB. A molecular basis for nicotine as a gateway drug. N Engl J Med. 2014;371(10):932-43. doi: 10.1056/NEJMsa1405092.
47. Kozlowski LT, Strasser AA, Giovino GA, Erickson PA, Terza JV. Applying the risk/use equilibrium: Use medicinal nicotine now for harm reduction. Tob Control. 2001;10(3):201-3. doi: 10.1136/tc.10.3.201.
48. Laaksonen M, Rahkonen O, Karvonen S, Lahelma E. Socioeconomic status and smoking. Eur J Public Health. 2005;15(3):262-9. doi: 10.1093/eurpub/cki115.
49. Garrett BE, Dube SR, Trosclair A, Caraballo RS, Pechacek TF. Cigarette smoking - United States, 1965-2008. Morb Mortal Wkly Rep. 2011;60(Suppl):109-13.
50. Delnevo CD, Giovenco DP, Ambrose BK, Corey CG, Conway KP. Preference for flavoured cigar brands among youth, young adults and adults in the USA. Tobacco Control. 2014. doi: 10.1136/tobaccocontrol-2013-051408
51. Chatham-Stephens K, Law R, Taylor E, Melstrom P, Bunnell R, Wang B, et al. Notes from the field: calls to poison centers for exposures to electronic cigarettes--United States, September 2010-February 2014. MMWR Morb Mortal Wkly Rep. 2014;63(13):292-3.
52. Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control. 2014;23(1):77-8. doi: 10.1136/tobaccocontrol-2012-050604.
53. Centers for Disease Control and Prevention. Bidi use among urban youth - Massachussetts, March-April. Morb Mortal Wkly Rep. 1999;48:796-9.
54. Burstyn I. Peering through the mist: Systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health. 2014;14. doi: 10.1186/1471-2458-14-18
55. Centers for Disease Control and Prevention. State laws prohibiting sales to minors and indoor use of electronic nicotine delivery systems - United States, November 2014. Morb Mortal Wkly Rep. 2014;63(49):1145-83.
56. Dutra LM, Glantz SA. Electronic cigarettes and conventional cigarette use among us adolescents: a cross-sectional study. JAMA Pediatr. 2014;168(7):610-7. doi: 10.1001/jamapediatrics.2013.5488.
57. Niaura RS, Glynn TJ, Abrams DB. Youth experimentation with e-cigarettes: another interpretation of the data. JAMA. 2014;312(6):641-2. doi: 10.1001/jama.2014.6894.
58. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer I. 1999;91(14):1194-210. doi: 10.1093/jnci/91.14.1194.
59. Phillips C, Wang C, Guenzel B. You might as well smoke: the misleading and harmful public message about smokeless tobacco. BMC Public Health. 2005;5(1):31.
60. Hall W, Gartner C, Forlini C. Ethical issues raised by a ban on the sale of electronic nicotine devices. Addiction. 2015;110(7):1061-7. doi: 10.1111/add.12898.
61. Andrew-Gee E. I vape, therefore I am: How vaping evolved from a smoking cessation aid into a lifestyle. The Globe and Mail. 2016, February 26. http://www.theglobeandmail.com/life/health-and-fitness/health/how-vaping-evolved-from-a-smoking-cessation-aid-into-a-lifestyle/article28912760/. Accessed 3 May 2016.
62. World Health Organization. 2014. Electronic nicotine delivery systems: Report by WHO. Conference of the Parties to the WHO Framework Convention on Tobacco control. Sixth session, Moscow, Russian Federation, 13-18 October 2014.. http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf. Accessed 7 Dec 2015
63. Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping? Indoor Air. 2013;23(1):25-31. doi: 10.1111/j.1600-0668.2012.00792.x.
64. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23(2):ii11-ii7. doi: 10.1136/tobaccocontrol-2013-051482.
65. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol. 2012;34(4):529-37. doi: 10.1016/j.reprotox.2012.08.001.
66. Kmietowicz Z. E-cigarettes latest: users on the up but rules tighten. BMJ. 2014;349:g6444. doi: 10.1136/bmj.g6444.
67. Chapman S. E-cigarettes: the best and the worst case scenarios for public health: an essay by Simon Chapman. BMJ. 2014;349:g5512. doi: 10.1136/bmj.g5512.
68. Philip Morris International. Regulating Tobacco Products: Harm Reduction. 2015. http://www.pmi.com/eng/tobacco_regulation/regulating_tobacco/pages/harm_reduction_old.aspx. Accessed 20 March 2015.